MSD has announced a takeover deal for Cidara Therapeutics, an infectious disease specialist currently focused on developing a preventive antibody-based therapy for influenza. The agreement – first ...
About one in eight Americans have tried GLP-1 drugs like Mounjaro, Zepbound and Ozempic — and they’ve shrunken appetites so ...
Six pilot training programs and eight certifications are being established to provide fundamental skills in using both armed ...
The Trump administration announced a new demonstration program aimed at easing access to GLP-1 receptor agonists for ...